Stock listing

NASDAQ:RKDA Arcadia Biosciences, Inc. Stock

Home listing (NASDAQ) of Arcadia Biosciences, Inc.

Follow Arcadia Biosciences, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:RKDA

$0.173 USD -0.015 (-8.1%)

Close on Nov 20, 2026

Past year -95.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.160 – $0.180 USDNov 20, 2026
Volume
119,029 sharesNov 20, 2026
Market cap
$1.05M USDAt the close on Nov 20, 2026 · price × 6.07M shares outstanding
52-week range
$0.111 – $3.870 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$597,024 USDMedian day 173,100 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Arcadia Biosciences, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:RKDA · Home$0.173 USD-0.015 (-8.1%)119,029$0.165$0.180$0.160$0.188Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RKDA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.173-0.015-8.1%$0.165$0.180$0.160119,029
$0.188-0.002-1.0%$0.184$0.197$0.180137,934
$0.190-0.004-2.0%$0.189$0.194$0.185172,914
$0.194-0.024-11.2%$0.212$0.212$0.193154,937
$0.218-0.004-1.8%$0.210$0.225$0.186673,794
$0.222-0.016-6.6%$0.185$0.233$0.1772,562,114
$0.238+0.073+44.1%$0.156$0.288$0.14620,409,107
$0.165-0.001-0.5%$0.170$0.170$0.144206,806
$0.166+0.005+3.0%$0.165$0.171$0.155122,206
$0.161-0.006-3.6%$0.159$0.167$0.156173,100
$0.167+0.009+5.7%$0.154$0.170$0.142334,500
$0.158+0.003+1.9%$0.147$0.170$0.146125,100
$0.155-0.001-0.6%$0.144$0.160$0.143112,200
$0.156-0.002-1.3%$0.155$0.157$0.132248,700
$0.158-0.013-7.6%$0.163$0.166$0.132844,800
$0.171+0.013+8.2%$0.159$0.177$0.1534,028,500
$0.158-0.002-1.3%$0.161$0.162$0.15569,600
$0.160+0.008+5.3%$0.154$0.160$0.15275,500
$0.152-0.010-6.2%$0.158$0.162$0.15063,900
$0.1620.0000.0%$0.157$0.164$0.144213,700
$0.162+0.004+2.5%$0.156$0.170$0.151530,900
$0.158+0.005+3.3%$0.152$0.158$0.143185,500
$0.153+0.008+5.5%$0.139$0.155$0.137257,900
$0.145-0.020-12.1%$0.160$0.160$0.1111,155,100
$0.165-0.039-19.1%$0.190$0.190$0.160988,400
$0.204+0.003+1.5%$0.183$0.205$0.182726,100
$0.201-0.007-3.4%$0.204$0.215$0.15933,836,900
$0.208-0.018-8.0%$0.200$0.230$0.18721,283,500
$0.226-0.038-14.4%$0.257$0.260$0.210761,700
$0.264-0.010-3.6%$0.275$0.289$0.232390,200
$0.274-0.013-4.5%$0.290$0.290$0.263210,100
$0.287-0.011-3.7%$0.295$0.300$0.270311,200
$0.298+0.011+3.8%$0.284$0.307$0.273765,300
$0.287-0.001-0.3%$0.288$0.292$0.270154,200
$0.288+0.004+1.4%$0.270$0.288$0.267208,300
$0.284+0.004+1.4%$0.270$0.289$0.255936,300
$0.280-0.001-0.4%$0.259$0.289$0.22221,107,500
$0.281-0.027-8.8%$0.305$0.306$0.2501,000,000
$0.3080.0000.0%$0.301$0.318$0.2852,850,800
$0.308-0.008-2.5%$0.300$0.310$0.279689,400
$0.316-0.110-25.8%$0.321$0.349$0.310887,100
$0.426-0.022-4.9%$0.445$0.680$0.28025,504,300
$0.448+0.008+1.8%$0.466$0.466$0.42010,200
$0.440-0.014-3.1%$0.460$0.466$0.4328,200
$0.454-0.024-5.0%$0.447$0.499$0.44346,600
$0.478+0.018+3.9%$0.440$0.483$0.43125,200
$0.460+0.029+6.7%$0.410$0.480$0.41043,100
$0.431-0.018-4.0%$0.449$0.449$0.42629,700
$0.449+0.018+4.2%$0.430$0.449$0.410173,100
$0.431-0.022-4.9%$0.435$0.443$0.40019,100
$0.453-0.027-5.6%$0.450$0.472$0.45021,400
$0.480+0.010+2.1%$0.460$0.480$0.45034,400
$0.470-0.003-0.6%$0.470$0.480$0.44872,000
$0.473+0.001+0.2%$0.469$0.480$0.46513,000
$0.472-0.038-7.5%$0.502$0.505$0.46078,800
$0.510+0.006+1.2%$0.486$0.510$0.48035,600
$0.504-0.015-2.9%$0.505$0.540$0.49068,400
$0.519-0.011-2.1%$0.539$0.540$0.48163,700
$0.530+0.017+3.3%$0.500$0.549$0.500155,400
$0.513-0.002-0.4%$0.500$0.514$0.47850,600
$0.515+0.025+5.1%$0.500$0.515$0.480108,600
$0.490+0.009+1.9%$0.466$0.500$0.46456,800
$0.481+0.023+5.0%$0.478$0.500$0.440264,900
$0.458-0.004-0.9%$0.470$0.470$0.44540,500
$0.462+0.020+4.5%$0.451$0.463$0.45162,600

Splits

2 splits since 2018 · NASDAQ:RKDA · every price before a split is adjusted for it

DayRatioWhat
1-for-40Consolidation
1-for-20Consolidation
Ticker
NASDAQ:RKDA
Asset type
Stock
Sector
Consumer goods
Industry
Food & drinks
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Arcadia Biosciences, Inc. news

Arcadia Biosciences, Inc. on 6ix

Sector
Consumer goods
Industry
Food & drinks
News releases
8 in the last 12 months · 108 in all · newest Nov 12, 2026 · oldest 2019
Calls
16 calls with a replay · 16 with a transcript · latest May 8, 2025
Decks
32 decks · latest Dec 11, 2024

Where Arcadia Biosciences, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RKDA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:RKDABOATSUnited StatesUSD
gettex:17DgettexGermanyEUR
LS Exchange:A3D7B0LS ExchangeGermanyEUR
Frankfurt:17DFrankfurtGermanyEUR
Lang & Schwarz:A3D7B0Lang & SchwarzGermanyEUR
Munich:17DMunichGermanyEUR

Valuation

EV/sales −0.4× against a median of 0.9×: the lowest of 10 Food & drinks companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$1.80M USD
P/E
Loss
EV/sales
−0.4×
EV/EBITDA
Negative EBITDA
Price/book
0.4×
Gross margin
41.1%
Operating margin
−69.0%
Net margin
−202.1%
Debt to equity
0.0×
Beta vs S&P 500
1.10

Food & drinks: the 10 companies nearest in size, of 642 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Arcadia Biosciences, Inc. · NASDAQ:RKDAUS$1.05M−US$1.80Mn/a−0.4×n/a0.4×−202.1%0.0×1.10
Saudigold Group Bhd · MYX:SGUS$2.47MUS$21,3826.4×0.0×0.0×0.1×1.8%0.0×n/a
Rocky Mountain High Brands, Inc. · OTC:RMHBUS$2.27MUS$6.84M157×12.8×n/an/a2.7%n/a1.33
Eneco Refresh Limited · ASX:ERGUS$2.16MUS$1.18M7.3×0.1×1.1×0.4×2.5%0.4×n/a
Elixinol Wellness Ltd · ASX:EXLUS$1.80MUS$3.81Mn/a0.4×n/a0.4×−35.5%0.6×n/a
Browar Czarnkow SA · NEWCONNECT:BROUS$1.55MUS$1.55Mn/a0.9×n/an/a−25.1%n/an/a
Caduceus Software Systems Corp. · OTC:CSOCUS$1.33MUS$10.73Mn/a1.8×n/an/a−59.3%n/a-0.18
Sentient Brands Holdings Inc. · OTC:SNBHUS$1.31MUS$976,880n/an/an/an/an/an/a0.68
Arctic Blue Beverages AB · OMXSTO:ARCTICUS$1.02MUS$2.46Mn/a6.8×n/an/a−324.9%n/an/a
American Rebel Holdings, Inc. · NASDAQ:AREBUS$1.02MUS$803,366n/a0.1×n/an/a−362.5%n/a1.40
Canyon Creek Food Company Ltd. · TSXV:CYFUS$490,188US$14.89Mn/a1.5×n/an/a−10.2%n/a-0.66
Median of the othersUS$1.44MUS$2.01M7.3×0.9×0.6×0.4×−25.1%0.4×0.68

Forecasts

Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.

Price target
12.00 USD · Analysts' mean
EPS, year to Dec 2025
-2.56 · 1 analyst

Team and board

DirectorRole
Kevin ComcowichChair of the Board
Amy YoderDirector
Gregory D. WallerDirector
Lilian Shackelford MurrayDirector

Events

Calls

CallWhenStatus
Arcadia Biosciences (NASDAQ:RKDA) Q1 2025 Earnings CallThu, May 08, 2025 · 2:00 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q4 2024 Earnings CallThu, Mar 20, 2025 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q3 2024 Earnings CallTue, Nov 12, 2024 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q1 2024 Earnings CallThu, May 09, 2024 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q4 2023 Earnings CallThu, Mar 28, 2024 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q3 2023 Earnings CallThu, Nov 09, 2023 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q2 2023 Earnings CallThu, Aug 10, 2023 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q1 2023 Earnings CallThu, May 11, 2023 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q4 2022 Earnings CallFri, Mar 31, 2023 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q3 2022 Earnings CallThu, Nov 10, 2022 · 4:30 PM ETReplay
All 16 calls
CallWhenStatus
Arcadia Biosciences (NASDAQ:RKDA) Q2 2022 Earnings CallThu, Aug 11, 2022 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q1 2022 Earnings CallThu, May 12, 2022 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q4 2021 Earnings CallWed, Mar 30, 2022 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q3 2021 Earnings CallMon, Nov 15, 2021 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q2 2021 Earnings CallMon, Aug 16, 2021 · 4:30 PM ETReplay
Arcadia Biosciences (NASDAQ:RKDA) Q1 2021 Earnings CallMon, May 17, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 12, 2026−8.3%
Q2 2026Aug 13, 2026−10.7%
Q1 2026May 15, 2026−12.6%
Q4 2025Mar 19, 2026 · After close+6.1%
Q3 2025Nov 7, 2025 · After close−2.2%
Q2 2025Aug 14, 2025 · After close+5.6%
Q1 2025May 7, 2025 · Before open−2.0%
Q4 2024Mar 20, 2025 · After close−4.5%
Q3 2024Nov 12, 2024 · After close−1.2%
Q2 2024Aug 13, 2024 · After close−11.0%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · After close−0.8%
Q4 2023Mar 28, 2024 · After close−7.2%
Q3 2023Nov 9, 2023 · After close−3.5%
Q2 2023Aug 10, 2023 · After close−2.7%
Q1 2023May 15, 2023 · After close−2.4%
Q4 2022Mar 30, 2023 · After close−5.1%
Q3 2022Nov 10, 2022 · After close−6.4%
Q2 2022Aug 11, 2022 · After close+12.6%
Q1 2022May 12, 2022 · After close+18.8%
Q4 2021Mar 30, 2022 · After close−25.9%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (December 2024)Merger or acquisition19 slidesDec 11, 2024
Investor Presentation (September 2023)Investor deck34 slidesSeptember 2023
Investor Presentation (November 2021)Investor deck17 slidesNovember 2021
Q1 2021 Earnings PresentationEarnings10 slidesMay 17, 2021
H.C. Wainwright Global Life Sciences Conference 2021Conference16 slidesMarch 2021
Q3 2019 Earnings PresentationEarnings7 slidesNov 6, 2019
Q2 2019 Earnings PresentationEarnings7 slidesAug 14, 2019
Q1 2019 Earnings PresentationEarnings9 slidesMay 8, 2019
Spring Investor Summit 2019Conference15 slidesApr 1, 2019
NobleConXV, 15th Annual Investor Conference (January 2019)Conference19 slidesJanuary 2019
All 32 decks
DeckKindSlidesDate
Rodman & Renshaw 20th Annual Global Investment Conference (September 2018)Conference20 slidesSep 5, 2018
Q2 2018 Earnings PresentationEarnings8 slidesAug 8, 2018
Q1 2018 Earnings PresentationEarnings11 slidesMay 9, 2018
Investor Presentation (April 2018)Investor deck18 slidesApril 2018
FY2017 Earnings PresentationEarnings11 slidesMar 20, 2018
Q3 2017 Earnings PresentationEarnings11 slidesNov 9, 2017
Investor Presentation (September 2017)Investor deck18 slidesSeptember 2017
Q2 2017 Earnings PresentationEarnings10 slidesAug 10, 2017
Q1 2017 Earnings PresentationEarnings10 slidesMay 10, 2017
Q4 2016 Earnings PresentationEarnings11 slidesMar 8, 2017
Q3 2016 Earnings PresentationEarnings12 slidesNov 10, 2016
Q2 2016 Earnings PresentationEarnings11 slidesAug 9, 2016
Investor Presentation (May 2016)Investor deck22 slidesMay 24, 2016
Q1 2016 Earnings PresentationEarnings13 slidesMay 10, 2016
FY2015 Earnings PresentationEarnings14 slidesMar 8, 2016
Bank of America Merrill Lynch Global Agriculture and Chemicals Conference 2016Conference9 slidesMar 3, 2016
Morgan Stanley Global Chemicals and Agriculture Conference 2015Conference18 slidesNov 9, 2015
Q3 2015 Earnings PresentationEarnings11 slidesNov 5, 2015
Non-Deal Roadshow (October 2015)Roadshow20 slidesOctober 2015
Credit Suisse 6th Annual Small & Mid Cap Conference 2015Conference16 slidesSep 17, 2015
Q2 2015 Earnings PresentationEarnings9 slidesAug 10, 2015
Investor Presentation (July 2015)Investor deck24 slidesJuly 2015

Open Decks

Financings

RaiseDate
Private placement of common stock (or pre-funded warrants) with Series A-1 and A-2 preferred investment options
Closed: US$4M raised · US$1.03 a share · Warrants at US$0.91 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Jun 13, 2026
Warrant exercise of preferred investment options exercised for common stock
Announced: about US$2.1M · US$2.575 a share · Warrants at US$2.325 for 30 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Jan 12, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$8.00 a share on May 14, 2015.

Price
US$8.00 a share
Shares offered
8,200,000 shares of common stock
Offering size
US$65.6 million
Listing
RKDA on the Nasdaq Global Market
Underwriters
Credit Suisse, J.P. Morgan, Piper Jaffray · In the order on the cover
Shares delivered
On or about May 20, 2015

Steps

StepWhen
Draft sent to the SEC in confidenceNov 12, 2014
Filed publiclyFeb 17, 2015
Amended 4 timesNewest May 14, 2015
Shares registered with an exchangeMay 8, 2015
Declared effective by the SECMay 14, 2015
Final prospectus, with the priceMay 15, 2015

Open IPO · From the cover of the final prospectus (424B4) filed May 15, 2015

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue4.86M5.04M4.45M7.42M6.78M8.03M1.17M1.46M4.03M3.19M
Cost of revenue3.10M2.96M2.17M6.10M8.71M5.20M885.0K661.0K283.0K895.0K
Gross profit1.76M2.08M2.28M1.32M-1.93M2.83M284.0K803.0K3.74M2.29M
Research and development9.00K53.0K64.0K1.51M3.89M7.96M7.10M6.07M7.41M8.66M
Selling, general and administrative7.00M9.64M8.23M15.0M22.9M16.5M13.6M11.6M10.7M12.3M
Operating income-2.50M-3.65M-6.10M-14.0M-35.5M-12.8M-19.4M-16.9M-14.3M-18.6M
Depreciation and amortization32.0K58.0K111.0K439.0K929.0K632.0K194.0K154.0K279.0K304.0K
EBITDA-2.47M-3.59M-5.99M-13.6M-34.6M-12.1M-19.2M-16.7M-14.0M-18.3M
Interest expense289.0K20.0K47.0K5.00K2.56M747.0K1.32M
Income before tax-2.33M-4.31M-5.32M-10.8M-16.1M-6.15M-28.9M-13.5M-15.7M-19.6M
Income tax8.00K8.00K8.00K14.0K2.00K-124.0K2.00K10.0K26.0K25.0K
Net income-2.34M-7.04M-14.0M-15.4M-14.7M-4.66M-28.8M-13.5M-15.7M-19.6M
Earnings per share, basic-1.71-5.17-11.29-25.65-27.56-0.47-4.53-3.58-7.28-8.85
Earnings per share, diluted-1.71-5.17-11.29-25.65-27.56-0.47-4.53-3.58-7.28-8.85

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents259.0K4.24M6.52M20.6M28.7M14.0M8.42M12.0M9.13M2.01M
Short-term investments4.30M05.12M0011.6M16.9M9.82M3.90M48.5M
Receivables425.0K1.18M514.0K1.22M1.37M1.41M602.0K165.0K1.23M349.0K
Inventory1.21M904.0K837.0K2.32M4.43M3.81M1.79M181.0K229.0K252.0K
Current assets6.36M9.24M15.0M25.4M35.4M31.7M28.4M22.9M15.0M52.2M
Property, plant and equipment8.00K41.0K70.0K680.0K2.29M3.54M1.80M395.0K299.0K508.0K
Goodwill0408.0K000
Total assets6.55M13.5M19.7M28.9M43.9M47.3M32.6M24.0M16.6M56.6M
Accounts payable1.45M703.0K801.0K905.0K1.41M726.0K492.0K285.0K366.0K222.0K
Current liabilities2.06M2.56M3.59M4.21M5.04M6.31M5.71M3.05M3.52M3.13M
Long-term debt02.10M107.0K025.1M
Total debt155.0K1.01M2.02M02.10M107.0K0025.1M
Total liabilities2.41M7.29M7.00M8.02M12.7M18.8M24.2M11.2M8.56M34.4M
Shareholders' equity4.14M6.22M12.8M21.0M31.1M27.7M7.71M12.8M8.01M22.2M
Shares outstanding1.37M1.36M1.29M616.1K554.6K13.5M8.65M4.77M2.13M2.22M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-4.70M-9.63M-15.3M-14.0M-25.9M-30.2M-17.2M-13.6M-14.0M-17.1M
Capital spending0-16.0K-5.00K-72.0K-1.01M-2.33M-1.48M-250.0K-79.0K-231.0K
Free cash flow-4.70M-9.64M-15.3M-14.0M-26.9M-32.6M-18.7M-13.9M-14.0M-17.3M
Cash from investing750.0K7.34M-4.34M1.42M16.6M17.3M-8.37M-5.97M47.2M-5.30M
Cash from financing6.00K9.00K5.51M4.52M21.9M20.6M22.0M22.5M-26.1M396.0K
Dividends paid00
Share buybacks25.1M9.42M5.29M10.0M24.0K442.0K
Change in cash-3.98M-2.28M-14.1M-8.04M12.6M7.63M-3.58M2.87M7.11M-22.0M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
8-K · Current reportNov 12, 2026ResultsSEC
S-8 · Registration statement for employee plansSep 30, 2026Offer documentSEC
SCHEDULE 13G · Big-stake noticeSep 30, 2026Big-stake noticeSEC
8-K · Current reportSep 15, 2026Management or board changeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportSep 4, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportAug 13, 2026ResultsSEC
ARS · Annual report to shareholdersAug 10, 2026Annual reportSEC
DEF 14A · Proxy statementAug 10, 2026Meeting noticeSEC
8-K · Current reportAug 7, 2026Current reportSEC
PRE 14A · Preliminary proxy statementJul 31, 2026Meeting noticeSEC
EFFECT · Notice that a registration is effectiveJul 9, 2026Other filingsSEC
424B3 · ProspectusJul 8, 2026Offer documentSEC
8-K · Current reportJul 2, 2026Management or board changeSEC
DJun 26, 2026Other filingsSEC
S-3 · Registration statementJun 26, 2026Offer documentSEC
8-K · Current reportJun 15, 2026Material contractSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 14, 2026ResultsSEC
10-K/A · Annual report, amendedApr 30, 2026Annual reportSEC
8-K · Current reportApr 3, 2026Current reportSEC
10-K · Annual reportMar 26, 2026Annual reportSEC
8-K · Current reportMar 26, 2026ResultsSEC
EFFECT · Notice that a registration is effectiveFeb 11, 2026Other filingsSEC
424B3 · ProspectusFeb 10, 2026Offer documentSEC
8-K · Current reportFeb 6, 2026Management or board changeSEC
CORRESP · Letter to the SECFeb 5, 2026Other filingsSEC
UPLOAD · Letter from the SECFeb 5, 2026Other filingsSEC
CORRESP · Letter to the SECJan 27, 2026Other filingsSEC
S-3 · Registration statementJan 27, 2026Offer documentSEC
DJan 26, 2026Other filingsSEC
RW · Request to withdraw a registrationJan 16, 2026Other filingsSEC
8-K · Current reportJan 13, 2026Material contractSEC
425Dec 29, 2025Other filingsSEC
8-K · Current reportDec 29, 2025Current reportSEC
8-K · Current reportDec 23, 2025Meeting outcomeSEC
ARS · Annual report to shareholdersNov 19, 2025Annual reportSEC
DEF 14A · Proxy statementNov 19, 2025Meeting noticeSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
8-K · Current reportNov 7, 2025ResultsSEC
8-K · Current reportOct 24, 2025Current reportSEC
8-K · Current reportAug 29, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeAug 19, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
425Aug 14, 2025Other filingsSEC
8-K · Current reportAug 14, 2025ResultsSEC
S-4/A · Registration statement, amendedJul 30, 2025Offer documentSEC
8-K · Current reportMay 16, 2025Current reportSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
425May 8, 2025Other filingsSEC
8-K · Current reportMay 8, 2025ResultsSEC
425May 2, 2025Other filingsSEC
8-K · Current reportMay 2, 2025Material contractSEC
10-K/A · Annual report, amendedApr 30, 2025Annual reportSEC
8-K · Current reportApr 3, 2025Material contractSEC
10-K · Annual reportMar 25, 2025Annual reportSEC
8-K · Current reportMar 20, 2025ResultsSEC
S-4 · Registration statementFeb 14, 2025Offer documentSEC
4 · Change in ownershipFeb 5, 2025Insider tradeSEC
4 · Change in ownershipFeb 5, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 3, 2025Big-stake noticeSEC
425Dec 11, 2024Other filingsSEC
8-K · Current reportDec 11, 2024Current reportSEC
425Dec 5, 2024Other filingsSEC
8-K · Current reportDec 5, 2024Material contractSEC
S-8 · Registration statement for employee plansNov 22, 2024Offer documentSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
8-K · Current reportNov 12, 2024ResultsSEC
8-K/A · Current report, amendedAug 23, 2024Management or board changeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 21, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
4 · Change in ownershipAug 20, 2024Insider tradeSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
8-K · Current reportAug 13, 2024ResultsSEC
8-K · Current reportAug 7, 2024Management or board changeSEC
3 · Initial statement of ownershipJul 18, 2024Insider tradeSEC
8-K · Current reportJul 8, 2024Management or board changeSEC
8-K · Current reportJul 1, 2024Meeting outcomeSEC
8-K · Current reportMay 20, 2024Acquisition or disposalSEC
8-K · Current reportMay 17, 2024Acquisition or disposalSEC
DEFA14A · Additional proxy materialMay 16, 2024Meeting noticeSEC
DEF 14A · Proxy statementMay 16, 2024Meeting noticeSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
8-K · Current reportMay 9, 2024ResultsSEC
10-K/A · Annual report, amendedApr 29, 2024Annual reportSEC
10-K · Annual reportMar 28, 2024Annual reportSEC
8-K · Current reportMar 28, 2024ResultsSEC
8-K · Current reportFeb 14, 2024Management or board changeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
4 · Change in ownershipFeb 5, 2024Insider tradeSEC
SC 13G · Big-stake noticeJan 3, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
8-K · Current reportNov 9, 2023ResultsSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
8-K · Current reportAug 10, 2023ResultsSEC
4 · Change in ownershipAug 7, 2023Insider tradeSEC
8-K · Current reportJul 20, 2023ResultsSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
4 · Change in ownershipJun 16, 2023Insider tradeSEC
8-K · Current reportJun 12, 2023Meeting outcomeSEC
4 · Change in ownershipMay 30, 2023Insider tradeSEC
S-8 · Registration statement for employee plansMay 25, 2023Offer documentSEC
10-Q · Quarterly reportMay 15, 2023Quarterly reportSEC
8-K · Current reportMay 11, 2023ResultsSEC
4 · Change in ownershipApr 28, 2023Insider tradeSEC
4 · Change in ownershipApr 28, 2023Insider tradeSEC
4 · Change in ownershipApr 28, 2023Insider tradeSEC
DEFA14A · Additional proxy materialApr 25, 2023Meeting noticeSEC
DEF 14A · Proxy statementApr 25, 2023Meeting noticeSEC
EFFECT · Notice that a registration is effectiveApr 18, 2023Other filingsSEC
424B3 · ProspectusApr 17, 2023Offer documentSEC
CORRESP · Letter to the SECApr 13, 2023Other filingsSEC
10-K/A · Annual report, amendedApr 13, 2023Annual reportSEC
UPLOAD · Letter from the SECApr 10, 2023Other filingsSEC
CORRESP · Letter to the SECApr 3, 2023Other filingsSEC
S-3 · Registration statementApr 3, 2023Offer documentSEC
10-K · Annual reportMar 30, 2023Annual reportSEC
8-K · Current reportMar 30, 2023ResultsSEC
424B3 · ProspectusMar 3, 2023Offer documentSEC
424B3 · ProspectusMar 3, 2023Offer documentSEC
424B3 · ProspectusMar 3, 2023Offer documentSEC
424B3 · ProspectusMar 3, 2023Offer documentSEC
424B3 · ProspectusMar 3, 2023Offer documentSEC
8-K · Current reportMar 3, 2023Material contractSEC
8-K · Current reportFeb 28, 2023Current reportSEC
8-K · Current reportFeb 22, 2023Meeting outcomeSEC
SC 13G · Big-stake noticeFeb 14, 2023Big-stake noticeSEC
4 · Change in ownershipFeb 2, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJan 20, 2023Big-stake noticeSEC
DEF 14A · Proxy statementJan 6, 2023Meeting noticeSEC
4 · Change in ownershipJan 5, 2023Insider tradeSEC
3 · Initial statement of ownershipJan 5, 2023Insider tradeSEC
8-K/A · Current report, amendedJan 5, 2023Management or board changeSEC
PRE 14A · Preliminary proxy statementDec 23, 2022Meeting noticeSEC
8-K · Current reportDec 8, 2022Current reportSEC
8-A12G · Registration of a class of sharesDec 8, 2022Other filingsSEC
8-K · Current reportNov 30, 2022Management or board changeSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
8-K · Current reportNov 10, 2022ResultsSEC
424B3 · ProspectusOct 7, 2022Offer documentSEC
EFFECT · Notice that a registration is effectiveOct 6, 2022Other filingsSEC
CORRESP · Letter to the SECOct 4, 2022Other filingsSEC
UPLOAD · Letter from the SECOct 3, 2022Other filingsSEC
S-1 · Registration statementSep 27, 2022Offer documentSEC
8-K · Current reportSep 27, 2022Current reportSEC
4 · Change in ownershipAug 18, 2022Insider tradeSEC
4 · Change in ownershipAug 18, 2022Insider tradeSEC
8-K · Current reportAug 16, 2022Material contractSEC
424B5 · ProspectusAug 16, 2022Offer documentSEC
10-Q · Quarterly reportAug 11, 2022Quarterly reportSEC
8-K · Current reportAug 11, 2022ResultsSEC
4 · Change in ownershipAug 3, 2022Insider tradeSEC
8-K · Current reportJun 7, 2022Management or board changeSEC
4 · Change in ownershipJun 3, 2022Insider tradeSEC
4 · Change in ownershipJun 3, 2022Insider tradeSEC
4 · Change in ownershipJun 3, 2022Insider tradeSEC
4 · Change in ownershipJun 3, 2022Insider tradeSEC
4 · Change in ownershipJun 3, 2022Insider tradeSEC
4 · Change in ownershipJun 3, 2022Insider tradeSEC
S-8 · Registration statement for employee plansMay 31, 2022Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 13, 2022Other filingsSEC
10-Q · Quarterly reportMay 12, 2022Quarterly reportSEC
8-K · Current reportMay 12, 2022ResultsSEC
CORRESP · Letter to the SECMay 10, 2022Other filingsSEC
UPLOAD · Letter from the SECApr 27, 2022Other filingsSEC
S-3 · Registration statementApr 21, 2022Offer documentSEC
DEFA14A · Additional proxy materialApr 19, 2022Meeting noticeSEC
DEF 14A · Proxy statementApr 19, 2022Meeting noticeSEC
4 · Change in ownershipApr 13, 2022Insider tradeSEC
4 · Change in ownershipApr 13, 2022Insider tradeSEC
10-K · Annual reportMar 31, 2022Annual reportSEC
8-K · Current reportMar 30, 2022ResultsSEC
424B3 · ProspectusFeb 11, 2022Offer documentSEC
SC 13G/A · Big-stake notice, amendedFeb 11, 2022Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveFeb 10, 2022Other filingsSEC
8-K · Current reportFeb 7, 2022Management or board changeSEC
SC 13G/A · Big-stake notice, amendedFeb 4, 2022Big-stake noticeSEC
4 · Change in ownershipFeb 4, 2022Insider tradeSEC
3 · Initial statement of ownershipFeb 4, 2022Insider tradeSEC

This page holds 200 of 599 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Arcadia Biosciences, Inc.’s releases · as of Nov 5, 2026

Common shares
6,065,211
Fully diluted
6,065,211

Fully diluted

LineSharesAs of
Common shares6,065,211Nov 5, 2026

Warrants and options

Lot
Warrants · US$0.91 · expiry not stated

Share count over time

CountShares
Nov 5, 20266,065,211
Jun 29, 2026

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Armistice Capital, LLC476K7.9%US$133KSep 30, 2026
Two Sigma30,9040.51%US$8,653Sep 30, 2026
Hrt Financial LP26,0920.43%US$7,000Sep 30, 2026
Jump Financial, LLC24,3010.40%US$6,804Sep 30, 2026
Citadel22,8870.38%US$6,408Sep 30, 2026
Geode Capital16,1350.27%US$4,517Sep 30, 2026
State Street12,1460.20%US$3,401Sep 30, 2026
Vanguard9,6440.16%US$2,700Sep 30, 2026
SBI Securities Co., Ltd.120<0.01%US$34Sep 30, 2026
TD70<0.01%US$19Sep 30, 2026
All 17 holders
HolderSharesOf the companyValueAs of
UBS44<0.01%US$13Sep 30, 2026
Group One Trading LLC18<0.01%US$5Sep 30, 2026
Pinnacle Financial Group, Inc.8<0.01%US$2Sep 30, 2026
Morgan Stanley2<0.01%US$1Sep 30, 2026
Southern Michigan Bank & Trust2<0.01%US$1Sep 30, 2026
Barclays1<0.01%Sep 30, 2026
Caitong International Asset Management Co., Ltd1<0.01%Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund27,8790.46%US$26,900May 31, 2026
Vanguard Extended Market Index Fund9,6440.16%US$6,549Jun 30, 2026
Fidelity Series Total Market Index Fund1,7160.03%US$1,656May 31, 2026
Fidelity Total Market Index Fund1,6260.03%US$1,569May 31, 2026

Big stakes

StakeStakeSharesDateFiling
MJL Manager LLC15.70%379KSep 25, 2026Schedule 13G
Armistice Capital, LLC9.99%517KSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gregory D. Waller
Other companies: Nuwellis, Inc. (Member of the Compensation Committee · Since at least Feb 14, 2012); Senorx Inc (Director · Mar 27, 2007 – Feb 26, 2010 · Past); Clarient Inc (Director · Dec 1, 2006 – Dec 22, 2010 · Past); Endologix Inc (Director · May 23, 2006 – Aug 12, 2020 · Past)
Director · Since at least Jun 7, 2017
Albert D Bolles
Other companies: Lifecore Biomedical, Inc. (Chief Executive Officer · May 8, 2014 – May 23, 2022 · Past); ConAgra Brands, Inc. (EVP & Chief Tech & Op Officer · Mar 14, 2014 – Jul 17, 2015 · Past)
Director · May 12, 2018 – Aug 19, 2024 · Past
Mark Wong
Other companies: S&W Seed Company (Director · Jun 30, 2015 – Dec 17, 2024 · Past); Green Brick Partners, Inc. (Director · Jan 16, 2008 – Mar 15, 2012 · Past)
Director · May 14, 2015 – Sep 9, 2015 · Past
Rajiv Shah
Other companies: Omeros Corporation (Director · Since at least Jun 14, 2015); Khosla Ventures Acquisition Co (Director · Mar 3, 2021 – Mar 3, 2021 · Past)
Director · May 14, 2015 – Aug 18, 2016 · Past
Amy Yoder
Other companies: Compass Minerals Intl Inc (Director · May 21, 2012 – Feb 14, 2023 · Past)
Director · Since at least Aug 7, 2017
Darby E Shupp
Other companies: Apollo Education Group Inc (Director · Mar 24, 2011 – Feb 1, 2017 · Past)
Director · May 14, 2015 – Aug 18, 2016 · Past
Deborah D Carosella
Other companies: Lifecore Biomedical, Inc. (Director · Mar 14, 2017 – Jun 4, 2022 · Past)
Director · Feb 22, 2021 – Aug 19, 2024 · Past
Eric J Rey
Other companies: 4Front Ventures Corp. (Director · Jan 1, 2021 – Jan 1, 2021 · Past)
Director · May 14, 2015 – Jun 3, 2019 · Past
George Frederick John Gosbee
Other companies: BioAmber Inc (BIOA) (Director · Feb 22, 2016 – Nov 9, 2016 · Past)
Director · May 14, 2015 – Jun 7, 2017 · Past
James Richard Reis
Other companies: Apollo Education Group Inc (Director · Jan 12, 2007 – Jul 6, 2010 · Past)
Director · May 14, 2015 – Jul 9, 2016 · Past
All 28 people
PersonSeat
Matthew T Plavan
Other companies: Origin Materials, Inc. (CFO and COO · Since at least Oct 30, 2023)
Chief Executive Officer · Sep 12, 2016 – Jan 21, 2021 · Past
Pamela Haley
Other companies: Origin Materials, Inc. (Interim CFO · Sep 1, 2023 – Sep 1, 2023 · Past)
Chief Financial Officer · Sep 1, 2019 – Aug 16, 2022 · Past
Sarah Reiter
Other companies: Cibus, Inc. (Chief Business Officer · May 1, 2021 – Jun 8, 2021 · Past)
Chief Commercial Officer · Mar 19, 2018 – Feb 3, 2020 · Past
Chris CuvelierChief Growth Officer · May 17, 2021 – May 17, 2021 · Past
Don EmlayVP Regulatory and Compliance · May 14, 2015 – Sep 10, 2015 · Past
Kevin ComcowichChair of the Board · Since at least Jun 1, 2022
Laura PitlikChief Marketing Officer · Jul 12, 2021 – Apr 4, 2023 · Past
Lilian Shackelford MurrayDirector · Since at least Jun 6, 2018
Mark KawakamiChief Financial Officer · Jul 5, 2024 – May 9, 2025 · Past
Matthew A AnkrumDirector · Jul 9, 2016 – Jul 9, 2016 · Past
Rajendra D KetkarChief Executive Officer, Director · May 23, 2016 – Jun 3, 2019 · Past
Randall ShultzChief Technology Officer · Apr 1, 2020 – Jan 21, 2021 · Past
Roger SalamehChief Operating Officer · May 14, 2015 – Aug 18, 2016 · Past
Stanley Jacot JrChief Executive Officer · Feb 2, 2022 – May 30, 2023 · Past
Thomas J SchaeferChief Executive Officer · Jan 3, 2023 – May 9, 2025 · Past
Vic C KnaufChief Scientific Officer, Director · May 14, 2015 – Aug 18, 2016 · Past
Wendy S NealVP, Chief Legal Officer · May 12, 2015 – Aug 18, 2016 · Past
Zhongjin LuVP Product Development · May 14, 2015 – Mar 23, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Arcadia Biosciences, Inc.